vs

Side-by-side financial comparison of APARTMENT INVESTMENT & MANAGEMENT CO (AIV) and Insight Molecular Diagnostics Inc. (IMDX). Click either name above to swap in a different company.

APARTMENT INVESTMENT & MANAGEMENT CO is the larger business by last-quarter revenue ($2.1M vs $1.1M, roughly 1.8× Insight Molecular Diagnostics Inc.). APARTMENT INVESTMENT & MANAGEMENT CO runs the higher net margin — 14155.2% vs -2015.4%, a 16170.6% gap on every dollar of revenue. On growth, APARTMENT INVESTMENT & MANAGEMENT CO posted the faster year-over-year revenue change (16.7% vs -23.4%). Insight Molecular Diagnostics Inc. produced more free cash flow last quarter ($-7.0M vs $-91.5M). Over the past eight quarters, Insight Molecular Diagnostics Inc.'s revenue compounded faster (154.4% CAGR vs -79.5%).

Beach Point Capital Management is an American hedge fund management firm headquartered in Santa Monica, California.The firm focuses on credit related investments.

Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.

AIV vs IMDX — Head-to-Head

Bigger by revenue
AIV
AIV
1.8× larger
AIV
$2.1M
$1.1M
IMDX
Growing faster (revenue YoY)
AIV
AIV
+40.0% gap
AIV
16.7%
-23.4%
IMDX
Higher net margin
AIV
AIV
16170.6% more per $
AIV
14155.2%
-2015.4%
IMDX
More free cash flow
IMDX
IMDX
$84.5M more FCF
IMDX
$-7.0M
$-91.5M
AIV
Faster 2-yr revenue CAGR
IMDX
IMDX
Annualised
IMDX
154.4%
-79.5%
AIV

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AIV
AIV
IMDX
IMDX
Revenue
$2.1M
$1.1M
Net Profit
$297.3M
$-23.0M
Gross Margin
42.5%
Operating Margin
-2057.5%
Net Margin
14155.2%
-2015.4%
Revenue YoY
16.7%
-23.4%
Net Profit YoY
2721.3%
31.5%
EPS (diluted)
$2.07
$-0.75

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AIV
AIV
IMDX
IMDX
Q4 25
$2.1M
$1.1M
Q3 25
$35.1M
$260.0K
Q2 25
$52.8M
$518.0K
Q1 25
$52.4M
$2.1M
Q4 24
$1.8M
$1.5M
Q3 24
$35.3M
$115.0K
Q2 24
$51.1M
$104.0K
Q1 24
$50.2M
$176.0K
Net Profit
AIV
AIV
IMDX
IMDX
Q4 25
$297.3M
$-23.0M
Q3 25
$283.1M
$-10.9M
Q2 25
$-19.3M
$-9.7M
Q1 25
$-13.9M
$-6.7M
Q4 24
$-33.5M
Q3 24
$-21.9M
$-13.5M
Q2 24
$-60.5M
$-4.5M
Q1 24
$-10.2M
$-9.1M
Gross Margin
AIV
AIV
IMDX
IMDX
Q4 25
42.5%
Q3 25
53.5%
Q2 25
67.6%
Q1 25
62.0%
Q4 24
40.0%
Q3 24
43.5%
Q2 24
48.1%
Q1 24
25.6%
Operating Margin
AIV
AIV
IMDX
IMDX
Q4 25
-2057.5%
Q3 25
51.9%
-4249.2%
Q2 25
56.0%
-1900.0%
Q1 25
55.9%
-318.0%
Q4 24
-2262.9%
Q3 24
50.0%
-11752.2%
Q2 24
55.9%
-4453.8%
Q1 24
57.8%
-5265.3%
Net Margin
AIV
AIV
IMDX
IMDX
Q4 25
14155.2%
-2015.4%
Q3 25
805.9%
-4174.6%
Q2 25
-36.6%
-1880.7%
Q1 25
-26.6%
-312.0%
Q4 24
-2255.1%
Q3 24
-62.1%
-11733.0%
Q2 24
-118.3%
-4355.8%
Q1 24
-20.3%
-5186.9%
EPS (diluted)
AIV
AIV
IMDX
IMDX
Q4 25
$2.07
$-0.75
Q3 25
$2.04
$-0.34
Q2 25
$-0.14
$-0.30
Q1 25
$-0.10
$-0.26
Q4 24
$-2.19
Q3 24
$-0.16
$-0.98
Q2 24
$-0.43
$-0.36
Q1 24
$-0.07
$-1.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AIV
AIV
IMDX
IMDX
Cash + ST InvestmentsLiquidity on hand
$394.9M
$11.6M
Total DebtLower is stronger
$738.6M
Stockholders' EquityBook value
$361.9M
$-31.5M
Total Assets
$1.7B
$25.8M
Debt / EquityLower = less leverage
2.04×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AIV
AIV
IMDX
IMDX
Q4 25
$394.9M
$11.6M
Q3 25
$404.4M
$18.7M
Q2 25
$41.4M
$24.3M
Q1 25
$49.1M
$31.0M
Q4 24
$141.1M
$8.6M
Q3 24
$82.6M
$3.4M
Q2 24
$88.5M
$9.3M
Q1 24
$121.8M
$5.6M
Total Debt
AIV
AIV
IMDX
IMDX
Q4 25
$738.6M
Q3 25
$828.5M
Q2 25
$1.1B
Q1 25
$1.1B
Q4 24
$829.7M
Q3 24
$1.3B
Q2 24
$1.2B
Q1 24
$1.2B
Stockholders' Equity
AIV
AIV
IMDX
IMDX
Q4 25
$361.9M
$-31.5M
Q3 25
$62.0M
$-9.2M
Q2 25
$91.7M
$1.1M
Q1 25
$110.5M
$10.2M
Q4 24
$123.0M
$-12.3M
Q3 24
$229.8M
$9.7M
Q2 24
$253.5M
$22.7M
Q1 24
$335.8M
$11.6M
Total Assets
AIV
AIV
IMDX
IMDX
Q4 25
$1.7B
$25.8M
Q3 25
$2.1B
$43.9M
Q2 25
$1.9B
$50.5M
Q1 25
$1.9B
$60.4M
Q4 24
$2.0B
$35.1M
Q3 24
$2.1B
$70.2M
Q2 24
$2.1B
$74.7M
Q1 24
$2.1B
$71.0M
Debt / Equity
AIV
AIV
IMDX
IMDX
Q4 25
2.04×
Q3 25
13.37×
Q2 25
11.99×
Q1 25
9.80×
Q4 24
6.75×
Q3 24
5.44×
Q2 24
4.78×
Q1 24
3.52×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AIV
AIV
IMDX
IMDX
Operating Cash FlowLast quarter
$8.1M
$-5.5M
Free Cash FlowOCF − Capex
$-91.5M
$-7.0M
FCF MarginFCF / Revenue
-4358.6%
-616.7%
Capex IntensityCapex / Revenue
4744.0%
129.9%
Cash ConversionOCF / Net Profit
0.03×
TTM Free Cash FlowTrailing 4 quarters
$-143.0M
$-25.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AIV
AIV
IMDX
IMDX
Q4 25
$8.1M
$-5.5M
Q3 25
$8.9M
$-4.5M
Q2 25
$9.7M
$-6.3M
Q1 25
$3.8M
$-5.9M
Q4 24
$47.0M
$-5.4M
Q3 24
$16.4M
$-5.5M
Q2 24
$8.0M
$-6.0M
Q1 24
$21.7M
$-3.8M
Free Cash Flow
AIV
AIV
IMDX
IMDX
Q4 25
$-91.5M
$-7.0M
Q3 25
$-19.3M
$-5.6M
Q2 25
$-16.8M
$-6.6M
Q1 25
$-15.4M
$-6.2M
Q4 24
$-113.0M
$-5.6M
Q3 24
$-19.6M
$-5.6M
Q2 24
$-28.9M
$-6.2M
Q1 24
$-19.2M
$-3.9M
FCF Margin
AIV
AIV
IMDX
IMDX
Q4 25
-4358.6%
-616.7%
Q3 25
-55.0%
-2135.4%
Q2 25
-31.8%
-1279.5%
Q1 25
-29.3%
-288.4%
Q4 24
-6280.2%
-374.5%
Q3 24
-55.4%
-4884.3%
Q2 24
-56.5%
-5931.7%
Q1 24
-38.3%
-2189.8%
Capex Intensity
AIV
AIV
IMDX
IMDX
Q4 25
4744.0%
129.9%
Q3 25
80.4%
403.8%
Q2 25
50.1%
67.4%
Q1 25
36.7%
14.4%
Q4 24
8890.4%
14.4%
Q3 24
101.9%
75.7%
Q2 24
72.2%
183.7%
Q1 24
81.5%
13.6%
Cash Conversion
AIV
AIV
IMDX
IMDX
Q4 25
0.03×
Q3 25
0.03×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AIV
AIV

Other Real Estate$2.0M97%
Other$66.0K3%

IMDX
IMDX

Segment breakdown not available.

Related Comparisons